相关实验视频
Updated: Mar 12, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.9K
慢性炎症是心血管和脏疾病之间被忽视的联系:聚焦介质素-6和C反应性蛋白
Pablo Pergola1, Richard J Johnson2, Adeera Levin3
1Renal Associates P.A., San Antonio, Texas.
概括
慢性炎症显著恶化慢性病 (CKD) 和心血管疾病 (CVD) 的结果. 监测诸如C反应蛋白 (CRP) 这样的炎症标志物可能有助于为心综合征提供新的抗炎疗法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性亚临床炎症是慢性病 (CKD) 和心血管疾病 (CVD) 进展的关键因素.
- 炎症和氧化应激会产生一种有害的循环,导致心综合征,恶化结果和死亡率.
- 生物标志物,如介质素-6和C反应蛋白 (CRP) 表明疾病的严重程度和预后在CKD和CVD患者.
研究的目的:
- 审查慢性炎症在CKD和CVD中确定的作用.
- 探索向炎症的潜力,以减少心脏病综合征的残留风险.
- 讨论炎症生物标志物对临床评估和新型治疗策略的影响.
主要方法:
- 对调查CKD和CVD炎症的研究进行文献综述.
- 分析炎症生物标志物的作用,特别是CRP和hsCRP.
- 检查当前治疗局限性和抗炎干预的可能性.
主要成果:
- 炎症是造成脏和心血管损伤的重要驱动因素,与死亡率增加有关.
- 高灵敏度C反应蛋白 (hsCRP) 作为残留炎症风险的预后标志物.
- 目前的治疗方法并不能完全解决炎症对疾病进展的影响.
结论:
- 临床医生应该考虑评估慢性病患者的慢性炎症,特别是那些患有心血管疾病的患者,使用hsCRP等标记物.
- 炎症风险是开发新型治疗方法的有希望的目标.
- 抗炎症策略可能对降低心综合征患者的残留风险至关重要.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
682
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
682
01:27Psychoneuroimmunology: Cardiovascular Disease
644
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
644
01:24Chronic Kidney Disease II: Clinical Manifestations
864
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
864
01:20The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
01:25Chronic Kidney Disease I: Introduction
936
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
936
01:38Inflammation
63.4K
Overview
63.4K